Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
Once-a-day Tacrolimus Conversion Study: The OneTAC Trial
for
Heart Failure
Location: Newark NJ
Sponsor: Newark Beth Israel Medical Center
Sex: All
Age: 18+
Code: NCT02545972
Recruiting
Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome
for
Smoking, Acute Coronary Syndrome
Location: Newark NJ
Sponsor: Newark Beth Israel Medical Center
Sex: All
Age: 18+
Code: NCT01170338
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Newark NJ, Hamilton NJ, New Windsor NY, Media PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase 3, Recruiting
An Investigation of Small Intestinal Carcinoid Carcinoma in Families
for
Carcinoid Carcinoma
Location: Newark NJ
Sponsor: Rutgers University
Sex: All
Age: 12+
Code: NCT00662168
Recruiting
Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
for
End Stage Liver DIsease
Location: Newark NJ
Sponsor: Proteonomix, Inc.
Sex: All
Age: 18 - 70+
Code: NCT01711073
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of Skeletal Maturity for Slipped Capital Femoral Epiphysis
for
Slipped Capital Femoral Epiphysis
Location: Newark NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 8 - 16
Code: NCT01220882
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: East Orange NJ, Flushing NY, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
for
HIV-1-infection
Location: Newark NJ, New Haven CT, Decarie Montreal, Quebec,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07708727
Phase 2, Phase 3, Recruiting
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors